Product correctly added to cart.

LRRK2-IN-1
View 3D

Biosynth logo

LRRK2-IN-1

CAS: 1234480-84-2

Ref. 3D-FL43177

5mgDiscontinued
10mgDiscontinued
25mgDiscontinued

Discontinued product. For inquiries about similar products, please fill out our form or email us at .


Product Information

Name:
LRRK2-IN-1
Synonyms:
  • 5,11-Dihydro-2-[[2-methoxy-4-[[4-(4-methyl-1-piperazinyl)-1-piperidinyl]carbonyl]phenyl]amino]-5,11-dimethyl-6H-pyrimido[4,5-b][1,4] benzodiazepin-6-one
Description:

LRRK2-IN-1 is a kinase inhibitor that targets the LRRK2 protein. It specifically inhibits the kinase domain of this protein, which has been implicated in the development and progression of cancer. LRRK2-IN-1 is a monoclonal antibody that binds to this domain and dephosphorylates it, leading to apoptosis in cancer cells. This drug also has pharmacokinetic properties that are suitable for administration by injection or infusion. The binding of LRRK2-IN-1 to its target leads to the disruption of mitochondrial membrane potential, which may be one of the mechanisms by which it causes cancer cell death. It also has anticancer activity against pancreatic cancer cells and other cancers with high levels of LRRK2 expression such as breast, lung, and ovarian cancers. In addition, LRRK2-IN-1 has been shown to inhibit cancer stem cells in colon and prostate cancers.

Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:

Chemical properties

Molecular weight:
570.69 g/mol
Formula:
C31H38N8O3
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Inquiry about discontinued product: 3D-FL43177 LRRK2-IN-1

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".